(PharmaNewsWire.Com, May 26, 2020 ) Benefits offered by robotic systems in pharmaceutical manufacturing is a key factor driving the growth of pharmaceutical robots market. The base year considered for the study is 2015, and the forecast has been provided for the period between 2016 and 2021.
The overall pharmaceutical robotic systems market is expected to grow from USD 64.37 million in 2016 to USD 119.46 million by 2021, at a CAGR of 13.2% from 2016 to 2021
A robotic system is a type of automation that has multiple axes of motion and can be programmed to perform a function. Some of the benefits of automation include efficiency, saving workers from hazardous environments or repetitive tasks, reducing training overhead, eliminating human error, increasing repeatability and reproducibility, and in cleanrooms, removing the potential for human contamination.
1. Introduction 2. Picking and Packaging 3. Inspection of Pharmaceutical Drugs 4. Laboratory Applications
On the basis of application, the global pharmaceutical robotic systems market is segmented into picking and packaging, inspection of pharmaceutical drugs, and laboratory applications. The picking and packaging segment accounted for the largest share of the global pharmaceutical robotic systems market.
Regional Growth, Development and Demand Analysis:
In 2015, the U.S. FDA approved 45 new medicines as compared to 27 in 2013. It also approved 98% of high-risk medical devices in 2014 as compared to 86% in 2013 and 70% in 2012. As the demand for new drugs and medicines grows, pharmaceutical companies are continuously looking for new ways to increase productivity, leading to an increased reliance on automated equipment and robotics.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
